DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Oligonucleotide Synthesis Market Size, Share, Development, Growth and Demand Forecast to 2023" report to their offering.
The global oligonucleotide synthesis market is expected to witness a CAGR of 10.5% during the forecast period, to reach $2,455.5 million by 2023.
Recent technological advancements in oligonucleotide synthesis and increasing support from government organizations are the key drivers of the global oligonucleotide synthesis market. The market is faced by challenges such as stringent regulations and lack of techniques for large scale synthesis of oligonucleotide. Growing focus on personalized medicine will create enormous revenue generation opportunities for the manufacturers in this market.
The global market on the basis of product is further segmented into synthesized oligonucleotides, reagents and equipment. Synthesized oligonucleotide is the largest segment of the global oligonucleotide synthesis market.
The global market on the basis of application is further segmented into research, diagnostic and therapeutic, with research being the largest application of the market.
The global market on the basis of end user is further segmented into academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies and others.
Some of the key players in the global market include LGC Biosearch Technologies, Inc., Bioautomation Corporation, Integrated DNA Technologies, Inc., GeneDesign, Inc., Trilink Biotechnologies LLC, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., General Electric Company and Eurogentec S.A.
Key Topics Covered:
1. Research Background
2. Research Methodology
3. Introduction
4. Market Size And Forecast By Product
5. Market Size And Forecast By Application
6. Market Size And Forecast By End User
7. Market Size And Forecast By Geography
8. Competitive Landscape
9. Company Profiles
- Lgc Biosearch Technologies, Inc.
- Bioautomation Corporation
- Integrated Dna Technologies, Inc.
- Genedesign, Inc.
- Trilink Biotechnologies Llc
- Merck Kgaa
- Eurofins Scientific Se
- Thermo Fisher Scientific Inc.
- General Electric Company
- Eurogentec S.A.
For more information about this report visit http://www.researchandmarkets.com/research/2mgpmf/global
